)
){kind=logo}
08:30
08:45
-
A conversation with BIO's CEO, John Crowley and Chair, Dr. Ted Love on Walking the Talk, leading with purpose and the promise of biotechnology and what it means for patients.
09:30
-
Access to medicines is a very real challenge, leaving patients in peril. Our speakers will discuss various policy barriers that prevent patients from getting the right medicine and the right time.
10:15
10:30
-
Despite the political headwinds, there are still significant opportunities for patient advocates to drive meaningful policies. Each of our speakers will deliver a mini-pitch on their chosen policy iss …
.jpg)
11:15
-
Inside the Beltway, it's easy to get tunnel vision and focus on Federal issues, but patient advocacy engagement in State Capitals is critically important as well. Our expert panel will discuss their w …
12:00
-
Meet and greet new partners, collaborators and allies during our lively and fun networking lunch!
13:00
-
Using The Moth’s seven principles of storytelling, developed through work with over 10,000 storytellers, MothWorks will deliver an engaging, interactive workshop designed to optimize and enhance your …
16:15
-
This inspiring Mom employed storytelling to educate lawmakers and win access to cutting edge therapy not just for her daughter, but for all kids in Texas who live with Rett Syndrome.
16:45
17:00
-
Reception will be located in the hotel restaurant Brickstones.
08:30
08:35
-
Be part of BIO's annual conversation on elections, punditry, partisanship and more
09:20
-
How are leading patient advocacy organizations scenario planning for the 119th Congress and Administration engagement post-Chevron? Join us to learn more!Speakers
10:15
10:30
-
Vector delivered gene therapies opened the floodgates to new technologies and targeted treatments. Hear from innovators driving the next generation of gene-based innovations bringing hope to patients
11:15
11:45
12:15
-
A conversation on rare disease innovation with FDA leadership
13:15
-
A panel discussion exploring the future of drug development and the Food and Drug Administration – reimagined. The session will discuss how the patient voice has historically shaped rare disease drug …
14:00
14:15
-
AI is everywhere, but what does it mean for patients? Learn how patient voices are shaping health AI, and how one AI program plans to drive cures forward.
15:00
-
More than ever before, patient advocacy organizations are being formed to drive therapeutic development for specific, and often very small populations. How can this work be optimized to avoid ‘reinven …Speakers
)
)
){kind=logo}
)
)
){kind=logo}
)
)
)
)
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}